Mayo Clinic News Network

News Resources

Items Tagged ‘News Release’

March 5th, 2015 · Leave a Comment

Mayo Clinic Named to Fortune’s “100 Best Companies to Work For” List

By Kelley Luckstein

ROCHESTER, Minn. — Fortune magazine named Mayo Clinic to its list of the “100 Best Companies Magazine cover with male hands creating a heart with his hands with the words "Best Companies to Work For" on the cover.to Work For” in 2015. This is Mayo’s 12th consecutive year on the magazine’s annual compilation of companies that rate high with employees. The list ranks Mayo Clinic 73 overall among the top 100 companies.

“We congratulate our employees for earning Mayo Clinic this distinction,” says John H. Noseworthy, M.D., president and CEO of Mayo Clinic. “We hope they take great pride in this ‘100 Best’ national recognition.”

Mayo Clinic was selected among hundreds of companies vying for a place on the list this year. Applicant companies opt to participate in the selection process, which includes an employee survey and an in-depth questionnaire about their programs and company practices. Great Place to Work® then evaluates each application using its unique methodology based on five dimensions: credibility, respect, fairness, pride and camaraderie. Great Place to Work® has found that employeeGonda-300x199s believe they work for great organizations when they consistently trust the people they work for, have pride in what they do and enjoy the people they work with.

Information from the survey of Mayo Clinic employees is available on the Great Rated! site.

The print copy of Fortune’s “100 Best Companies to Work For” edition will be on
newsstands March 9.

MEDIA CONTACT: Kelley Luckstein, Mayo Clinic Public Affairs, 507-284-5005
Email: newsbureau@mayo.edu Read the rest of this entry »

View full entry · Comment on this

Tags: 100 Best Companies to Work For, Dr. John Noseworthy, FORTUNE, News Release


March 3rd, 2015 · Leave a Comment

Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes

By Brian Kilen

NFC patch sensor

NFC patch sensor

ROCHESTER, Minn. — Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

“We are hoping that this technology will be game-changer. These patch biosensors may help us reduce global obesity and diabetes,” says James Levine, M.D., Ph.D., a Mayo Clinic endocrinologist and obesity researcher. “They are accurate, inexpensive, and can be integrated into the care people receive."

A first-of-its-kind, the wearable patch sensors are the size of a small bandage, and are designed to be painless, wireless and disposable. In the bandage is a sensor that communicates via a closed-loop diabetes management system which is compatible with cell phones. The system will allow researchers to monitor movement and develop treatments for obesity and related conditions.

Read the rest of this entry »

View full entry · Comment on this

Tags: diabetes, Mayo Clinic Ventures, News Release, News Release Minnesota, obesity, Research


March 3rd, 2015 · Leave a Comment

Mayo Clinic Releases PathWays: New Online “Case Study” Tool for Pathologists and Medical Enthusiasts

By Andy Tofilon

Mayo Clinic Pathways logo

Mayo Clinic fellows and residents publishing weekly practical case studies on the Mayo Medical Laboratories blog for medical professionals around the world.

ROCHESTER, Minn. — A dark purplish blob (a.k.a., a karyosome) floats randomly next to perfectly pink circles. Electric yellow spots stand out in a sea of stained dark blue cells, viewed at 40 times the original magnification. For a pathologist, this unique “artwork” provides vital information that will unlock needed medical diagnoses for sick patients. These scientific images — combined with brief patient descriptions — comprise Mayo Clinic PathWays — an online learning tool for pathologists and for those who enjoy learning about medicine. Mayo Medical Laboratories and Mayo Clinic’s Laboratory Medicine and Pathology Graduate Medical Education Office have developed this case-study tool that will offer weekly “challenges” posted to the Mayo Medical Laboratories website.

MEDIA CONTACT: Gina Chiri-Osmond, Public Affairs, 507-284-5005, newsbureau@mayo.edu Read the rest of this entry »

View full entry · Comment on this

Tags: case studies, Dr Bobbi Pritt, Mayo Clinic Laboratory Medicine, Mayo Clinic Pathology, Mayo Clinic PathWays, Mayo Medical Laboratories, Minnesota news release, News Release


March 3rd, 2015 · Leave a Comment

Mayo Clinic Reports Strong Performance in 2014, Extends Hope and Healing to Millions

By Karl W Oestreich

Dr. Noseworthy

Dr. Noseworthy

ROCHESTER, Minn. — Mayo Clinic reports a strong 2014 performance, including providing direct care for more than 1.3 million people, contributions of $410 million to its pension plan as a commitment to employees, and plans for a $1.5 billion investment to fund information technology infrastructure.

“Whether viewed through the lens of quality, patient outcomes, research advances, operational performance or sharing our knowledge with the world — by all measures, we had an extraordinary year,” says John Noseworthy, M.D., president and CEO, Mayo Clinic. “That success allowed us to reinvest in our people, our infrastructure and our mission so we can better serve our patients.”

Jeff Bolton

Jeff Bolton

“As a nonprofit organization, it’s important for us to not only reinvest in our technology infrastructure, but also invest in our employees,” says Jeff Bolton, vice president, administration, Mayo Clinic. To that end, Mayo Clinic made an additional contribution of $190 million to its pension fund, bringing the total 2014 contribution to $410 million. This additional investment was necessary to ensure Mayo Clinic will meet its commitment to current and future retirees.

“Our financial performance gives us the flexibility to invest in new initiatives that will help our patients,” says Kedrick Adkins Jr., Mayo chief financial officer. These funds are committed to mission-advancing projects. The funding includes five areas of focus, Adkins says:

Kedrick Adkins Jr.

Kedrick Adkins Jr.

  • Information technology infrastructure: $1.5 billion over multiple years to fund a new electronic health record and revenue cycle management system, network refresh and data transaction security upgrades.
  • Employee pension plan: $410 million contribution in 2014. This includes an originally planned $220 million contribution and an additional $190 million contribution as a commitment to fully fund the pension plan for employees.
  • Practice innovation: approximately $200 million in 2014 which includes funding of Mayo’s three hybrid centers — individualized medicine, regenerative medicine and the science of health care delivery — as well as Mayo Clinic practice priorities and information knowledge management activities.
  • Education: $275 million in 2014 funding for educational activities.
  • Research: $648 million in 2014 funding for research activities — $276 million from Mayo and $372 million from external resources.

Read the rest of this entry »

View full entry · Comment on this

Tags: Destination Medical Center, Dr. John Noseworthy, Dr Sameer Keole, electronic health record, Jeff Bolton, Mayo Clinic 2014 Performance Report, Mayo Clinic Care Network, Mayo Clinic Proton Beam Therapy Program, Minnesota news release, News Release


March 2nd, 2015 · Leave a Comment

U.S. Women’s Awareness of Breast Density Varies by Race and Ethnicity, Education and Income, Mayo Clinic Study Finds

By Joe Dangor

Disparities in the level of awareness and knowledge of breast density exist among U.S. women, according to the results of a Mayo Clinic study published in the Journal of Clinical Oncology.

Xray of non dense breast with cancer

Image A: Non-dense breast tissue showin.g a small cancer (upper left)

Breast density is the term used to describe the variation in dense tissue on a mammogram image. Fatty breast tissue appears more radiologically translucent than dense (fibroglandular) breast tissue. Regions of a breast that comprise fatty tissue will appear darker on a mammogram, while regions that comprise dense tissue appear whiter.

Dense breast w cancer

Image B: Dense breast tissue with palpable lump, cancer diagnosed (far right center)

Increased breast density has been shown to mask cancers on the mammogram as well as to be associated with future risk of breast cancer. Recent legislation in several states mandates that women be given information about breast density in order to guide decisions about breast cancer screening.

Researchers conducted a national cross-sectional survey of 2,311 women ages 40 to 74 in English and Spanish. The survey response rate was 65 percent. Overall, more than half of women who responded (58 percent) had heard of breast density, 49 percent were aware that breast density affects breast cancer detection and 53 percent knew that breast density is associated with cancer risk.

MEDIA CONTACT:
Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu.

Read the rest of this entry »

View full entry · Comment on this

Tags: Breast Cancer, breast density, Deborah Rhodes, disparities, Dr Rhodes, JCO, Journal of Clinical Oncology, M.D., Mayo Clinic, Minnesota news release, News Release


February 24th, 2015 · Leave a Comment

Decline in Smoking Rates May Increase Lung Cancer Mortality Due to Inadequate Screening Guidelines

By Joe Dangor

ROCHESTER, Minn. — A decline in smoking rates may mean that many people who could have benefited from early detection of lung cancer are dying because they don’t qualify for low-dose CT scans, according to a group of Mayo Clinic researchers. Their research appears in the Feb. 24 issue of JAMA, the journal of the American Medical Association.

“As smokers quit earlier and stay off cigarettes longer, fewer are eligible for CT screening, which has been proven effective in saving lives,” says Ping Yang, M.D., Ph.D., an epidemiologist at Mayo Clinic Cancer Center. “Patients who do eventually develop lung cancer are diagnosed at a later stage when treatment can no longer result in a cure.”

Dr. Yang says researchers and policymakers need to re-examine screening criteria to identify a greater proportion of patients who develop lung cancer.

MEDIA CONTACT:
Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu.

Read the rest of this entry »

View full entry · Comment on this

Tags: CT Scan, Dr Yang, JAMA, Lung Cancer, M.D., Minnesota news release, News Release, PhD, Ping Yang, Screening Guidelines, smoking rates, US Preventive Services Task Force


February 23rd, 2015 · Leave a Comment

Mayo Medical Laboratories and Seattle Children’s Hospital Partner in Effort to Lower Costs of Clinical Laboratory Tests

By Andy Tofilon

Mayo Clinic Children's Hospital

Mayo Medical Laboratories and Seattle Children's Hospital are collaborating to improve test utilization in children's hospitals around the country.

ROCHESTER, Minnesota – Mayo Medical Laboratories is partnering with Seattle Children’s Hospital to research and develop ways to help the children’s hospitals around the country decrease costs and potential errors associated with unnecessary laboratory testing.

“Mayo and Seattle Children’s have collaborated on this important issue for years,” says Don Flott, director of utilization management at Mayo Medical Laboratories. “Test utilization is one strategy both organizations use for performing appropriate laboratory and pathology testing with the goal of providing high-quality, cost-effective patient care.”

In 2014, Mayo became a Gold Sponsor of Seattle Children’s Pediatric Laboratory Utilization Guidance Services (PLUGS), which is a leading test-utilization program launched by the hospital in 2013.

MEDIA CONTACT: Andrew Tofilon, Mayo Clinic Marketing Administrator, 507-538-5245, newsbureau@mayo.edu. Read the rest of this entry »

View full entry · Comment on this

Tags: Don Flott, Dr Mike Astion, laboratory medicine, Mayo Medical Laboratories, Minnesota, Minnesota news release, News Release, seattle Children's hospital, Test Utilization


February 20th, 2015 · Leave a Comment

Mayo Clinic Trustees Welcome New Members, Recognize Named Professors

By Karl W Oestreich

Dr. Gianrico Farrugia

Dr. Gianrico Farrugia

PHOENIX — The Mayo Clinic Board of Trustees welcomed Gianrico Farrugia, M.D. ,as a new member, re-elected two internal trustees and one public trustee, and also recognized three recipients of Mayo Clinic named professorships at its board meeting today.

Dr. Farrugia was named Mayo Clinic vice president and chief executive officer (CEO) of Mayo Clinic's campus in Jacksonville, Florida, in August 2014. He replaces William Rupp, M.D., who retired at the end of 2014 and was elected as an emeritus trustee. Michael Powell, who joined the board in 2011, was re-elected as a public trustee. Powell, who is president and CEO of the National Cable & Telecommunications Association (NCTA), was chairman of the Federal Communications Commission (FCC) from 2001 to 2005 and a member of the FCC for eight years.

Dr. Veronique Roger

Dr. Veronique Roger

The board re-elected two internal trustees:

  • Pam Johnson, R.N., chair, Mayo Clinic Department of Nursing. Ms. Johnson will serve a one-year term.

The Mayo Clinic Board of Trustees also recognized three new named professorships, the highest academic distinction for faculty members at Mayo Clinic. Read the rest of this entry »

View full entry · Comment on this

Tags: Arizona News Release, Dr Barbara Bockaj, Dr. Gianrico Farrugia, Dr Richard Ehman, Dr Veronique Roger, Mayo Clinic Board of Trustees, Michael Powell, Minnesota news release, named professorships, News Release


February 20th, 2015 · Leave a Comment

Mayo Clinic Researchers Identify Gene that Pushes Normal Pancreas Cells to Change Shape, a Key Step to Cancer Development

By Kevin Punsky

The image shows typical pancreatic precancerous lesions. Brown staining shows upregulation of the protein PKD1.

The image shows typical pancreatic precancerous lesions. Brown staining shows upregulation of the protein PKD1.

JACKSONVILLE, Fla. — A research team led by investigators from Mayo Clinic’s campus in Jacksonville, Florida, and the University of Oslo, Norway, have identified a molecule that pushes normal pancreatic cells to transform their shape, laying the groundwork for development of pancreatic cancer — one of the most difficult tumors to treat.

Their findings, reported in Nature Communications, suggest that inhibiting the gene, protein kinase D1 (PKD1), and its protein could halt progression and spread of this form of pancreatic cancer, and possibly even reverse the transformation.

“As soon as pancreatic cancer develops, it begins to spread, and PKD1 is key to both processes. Given this finding, we are busy developing a PKD1 inhibitor that we can test further,” says the study’s co-lead investigator, Peter Storz, Ph.D., a cancer researcher at Mayo Clinic.

MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs,
904-953-0746. 
Email:punsky.kevin@mayo.edu

Read the rest of this entry »

View full entry · Comment on this

Tags: cancer, Dr Peter Storz, Florida, Florida News Release, Mayo Clinic, Mayo Clinic in Jacksonville, Medical Research, News Release, Pancreatic Cancer


February 19th, 2015 · Leave a Comment

MEDIA ADVISORY — Sen. Amy Klobuchar to Tour Mayo Clinic Biobank, Discuss the Precision Medicine Initiative; Media Welcome for Tour and Interviews

By Sam Smith

ROCHESTER, Minn. — Sen. Amy Klobuchar, D-Minn., will tour the Mayo Clinic Biobank and discuss the Precision Medicine Initiative with leadership from both the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories. Journalists are welcome to accompany Sen. Klobuchar and join the informational tour of Mayo Clinic’s multi-million-dollar investment in precision medicine. Mayo Clinic leadership will also be available for interviews and background discussions.

laboratory researcher working in Biobank labWHO: Minnesota Senator Amy Klobuchar; Richard Weinshilboum, M.D., acting director, Center for Individualized Medicine; Curtis Hanson, M.D., director, Mayo Medical Laboratories.

WHAT: Walking tour of the Mayo Clinic Biobank and the Biorepositories Program of the Mayo Clinic Center for Individualized Medicine. Photo opportunities and opportunities to discuss the Precision Medicine Initiative with Sen. Klobuchar and Mayo Clinic leadership.

WHERE: Biorepositories Building of Mayo Clinic, 2915 Valleyhigh Drive NW, Rochester, MN 55901. Entrance is behind the building.

WHEN: Friday, February 20, from 11:15 to 11:40 a.m.

NOTE: Members of the media should RSVP to 507-284-5005.

MEDIA CONTACT: Sam Smith, 507-284-5005, newsbureau@mayo.edu.

View full entry · Comment on this

Tags: Dr Curtis Hanson, Dr. Richard Weinshilboum, Mayo Medical Laboratories, Minnesota news release, News Release, Precision Medicine, Sen Amy Klobuchar